ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% Trademark

Trademark Overview

On Friday, March 29, 2019, a trademark application was filed for ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% with the United States Patent and Trademark Office. The USPTO has given the ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% trademark a serial number of 88362774. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Aerie Pharmaceuticals, Inc.. The ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%

General Information

Serial Number88362774
Word MarkROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%
Filing DateFriday, March 29, 2019
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6070570
Registration DateTuesday, June 2, 2020
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Description of MarkThe mark consists of the word "ROCKLATAN" in lower case block letters with the words "NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION" in lower case and in parentheses followed by "0.02%/0.005%" beneath the word "ROCKLATAN".
Goods and ServicesPharmaceutical preparations for the treatment of glaucoma and ocular hypertension
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2019
Primary Code005
First Use Anywhere DateTuesday, March 12, 2019
First Use In Commerce DateTuesday, March 12, 2019

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 17, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 15, 2020USE AMENDMENT FILED
Wednesday, April 15, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, April 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 7, 2020SOU EXTENSION 1 GRANTED
Thursday, February 6, 2020SOU EXTENSION 1 FILED
Tuesday, April 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 17, 2020NOTICE OF REVIVAL - E-MAILED
Monday, March 16, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, March 16, 2020PETITION TO REVIVE-GRANTED
Monday, March 16, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 6, 2019ASSIGNED TO LIE
Monday, April 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 19, 2019EXAMINER'S AMENDMENT ENTERED
Friday, April 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, April 19, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2019NEW APPLICATION ENTERED

Related Keywords

solution ophthalmic latanoprost netarsudil rocklatan ocular hypertension glaucoma treatment preparations pharmaceutical